Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
WHIM syndrome is an immunodeficiency disease characterized by neutropenia, hypogammaglobulinemia and extensive human papillomavirus (HPV) infection. Despite the peripheral neutropenia, bone marrow aspirates from affected individuals contain abundant mature myeloid cells, a condition termed myelokathexis. The susceptibility to HPV is disproportionate compared with other immunodeficiency conditions, suggesting that the product of the affected gene may be important in the natural control of this infection. We describe here the localization of the gene associated with WHIM syndrome to a region of roughly 12 cM on chromosome 2q21 and the identification of truncating mutations in the cytoplasmic tail domain of the gene encoding chemokine receptor 4 (CXCR4). Haplotype and mutation analyses in a pedigree transmitting myelokathexis as an apparently autosomal recessive trait support genetic heterogeneity for this aspect of the WHIM syndrome phenotype. Lymphoblastoid cell lines carrying a 19-residue truncation mutation show significantly greater calcium flux relative to control cell lines in response to the CXCR4 ligand, SDF-1, consistent with dysregulated signaling by the mutant receptor. The identification of mutations in CXCR4 in individuals with WHIM syndrome represents the first example of aberrant chemokine receptor function causing human disease and suggests that the receptor may be important in cell-mediated immunity to HPV infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alterations in GPCR signalling are implicated in the pathogenesis and treatment of neuropsychiatric55, immunological56, gastrointestinal57,58, cardiac59, renal, hormonal, infectious60 and many other disorders53,54.”
From Unexplored therapeutic opportunities in the human genome (2018) · cites this paper as [56]
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641 · cited 1×
“To date, their role in disease causation has been best established for the co-receptor function of CCR5 and CXCR4 in HIV infectio”
BackgroundParametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed · Cited by 2,877
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
Zou, Y.-R., Kottmann, A. H., Kuroda, M., Taniuchi, I., & Littman, D. R. (1998) · Nature · doi:10.1038/31269 · Cited by 2,489
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Ma, Q., Jones, D., Borghesani, P. R., Segal, R. A., Nagasawa, T., Kishimoto, T., Bronson, R. T., & Springer, T. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9448 · Cited by 1,682
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S.-I., et al. (1998) · Nature · doi:10.1038/31261 · Cited by 1,525
Multilocus linkage analysis in humans: detection of linkage and estimation of recombination.
Lathrop, M. G., Lalouel, J.-M., Julier, C., & Ott, J. (1985) · Europe PMC (PubMed Central) · Cited by 1,228
Burger, J. A., Tsukada, N., Burger, M., Zvaifler, N. J., Dell'Aquila, M., & Kipps, T. J. (2000) · Blood · doi:10.1182/blood.v96.8.2655 · Cited by 607 · cited 1×
“Moreover, CXCR4 and SDF-1 signaling has been shown to inhibit spontaneous apoptosis in human chronic lymphocytic leukemia B cell”
Background
Cited by
Items 401–500 of 724
Control of Secondary Granule Release in Neutrophils by Ral GTPase
Chen, C. X.-J., Soto, I., Guo, Y.-L., & Liu, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.154203 · Cited by 18
“The release of PMN from bone marrow is largely dependent on CXCR4 [9].”
BackgroundA case of WHIM syndrome associated with diabetes and hypothyroidism
Takaya, J., Fujii, Y., Higashino, H., Taniuchi, S., Nakamura, M., & Kaneko, K. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00503.x · Cited by 13
“(CXCR4), a G-protein-coupled receptor with a unique ligand, CXCL12 (also known as SDF-1), have been associated with this disorder (2).”
BackgroundSelf-citationLuo, J., Pascali, F. D., Richmond, G. W., Khojah, A. M., & Benovic, J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101551 · Cited by 13
“(2022) 298(2) 101551 expressing S339fs5 and R334X were transfected with the appropriate plasmid and selected and maintained in complete media supplemented with 0.”
MethodFurusato, B., & Rhim, J. S. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-267-4_2 · Cited by 13
Genetic Syndromic Immunodeficiencies with Antibody Defects
Ming, J. E., & Stiehm, E. R. (2008) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2008.06.007 · Cited by 14
Hagan, J. B., & Nguyen, P. L. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.9.1031 · Cited by 13
Sterling, J. C. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch33 · Cited by 15
Animal Models of Human Granulocyte Diseases
Schäffer, A. A., & Klein, C. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.10.005 · Cited by 15
Vitale, R. M., Thellung, S., Tinto, F., Solari, A., Gatti, M., Nuzzo, G., Ioannou, E., Roussis, V., Ciavatta, M. L., Manzo, E., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104337 · Cited by 12
Congenital Neutropenia and Rare Functional Phagocyte Disorders in Children
Walkovich, K. J., & Connelly, J. A. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.01.004 · Cited by 14
Galli, J., Pinelli, L., Micheletti, S., Palumbo, G., Notarangelo, L. D., Lougaris, V., Dotta, L., Fazzi, E. M., & Badolato, R. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1030-8 · Cited by 15
“Klein RS, Rubin JB. Immune and nervous system CXCL12 and CXCR4: parallel roles in patterning and plasticity.”
BackgroundInfluentialHeusel, J. W., & Ballas, Z. K. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200312000-00008 · Cited by 12
The role of a mutation of the CXCR4 gene in WHIM syndrome.
Taniuchi, S., Masuda, M., Fujii, Y., Izawa, K., Kanegane, H., & Kobayashi, Y. (2005) · PubMed · Cited by 12
Self-citationBibas, M., Castillo, J. J., & Sarosiek, S. (2024) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2024.061 · Cited by 20
MYD88 and CXCR4 Mutation Profiling in Lymphoplasmacytic Lymphoma/Waldenstrom’s Macroglobulinaemia
Vinarkar, S., Arora, N., Chowdhury, S. S., Saha, K., Pal, B., Parihar, M., Radhakrishnan, V. S., Chakrapani, A., Bhartia, S., Bhave, S. J., et al. (2018) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-018-0978-1 · Cited by 11
Genome-wide association study on 13 167 individuals identifies regulators of blood CD34+cell levels
Portilla, A. L. D. L., Ekdahl, L., Cafaro, C., Ali, Z., Miharada, N., Þorleifsson, G., Žemaitis, K., Arrizabalaga, A. L., Thodberg, M., Pertesi, M., et al. (2022) · Blood · doi:10.1182/blood.2021013220 · Cited by 14
Novel Role for NFAT3 in ERK-Mediated Regulation of CXCR4
Keven, H., Kiefer, C. M., & Kamal, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115249 · Cited by 11
“Among various biological processes, CXCR4 plays a critical role in WHIM syndrome, HIV entry, cancer progression and metastasis [1-3].”
BackgroundTransmembrane adaptor protein WBP1L regulates CXCR4 signalling and murine haematopoiesis
Borna, Š., Drobek, A., Kralova, J. S., Glatzová, D., Šplíchalová, I., Fabišik, M., Pokorna, J., Skopcova, T., Angelisová, P., Kanderová, V., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14895 · Cited by 12
Wagner, N., Mott, K., Upcin, B., Stegner, D., Schulze, H., & Ergün, S. (2021) · Cells · doi:10.3390/cells10040722 · Cited by 11
“Due to its role in immune cell development, mutations in CXCR4 can lead to lymphomas such as Waldenström’s macroglobulinemia [22] or congenital WHIM-syndrome [23].”
BackgroundChemokines key players in cancer progression and metastasis
Singh, S. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/s246 · Cited by 11
Combined Use of Cytokines, Hormones and Therapeutic Vaccines During Effective Antiretroviral Therapy
Imami, N., Westrop, S. J., Cranage, A., Burton, C. H., & Gotch, F. M. (2007) · Future HIV Therapy · doi:10.2217/17469600.1.2.171 · Cited by 11
“A genetic linkage of WHIM syndrome (an immunodeficiency disease) to a 19-residue truncation of CXCR4, indicates that caution should be exercised when developing CXCR4 inhibitors [25].”
BackgroundImmune deficiency disorders involving neutrophils
Spickett, G. P. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.051185 · Cited by 11
Majumdar, S., Pontejo, S. M., Jaiswal, H., Gao, J., Salancy, A., Stassenko, E. N., Yamane, H., McDermott, D. H., Balabanian, K., Bachelerie, F., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200871 · Cited by 10
Development and therapeutic perspectives of CXCR4 antagonists for disease therapy
Yang, J., Tian, E., Chen, L., Liu, Z., Ren, Y., Mao, W., Zhang, Y., & Zhang, J. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116594 · Cited by 13
Cell membranes cloaked magnetic nanoparticles for target recycling detection of nucleic acid
Shi, R., Fu, S., Xu, Y., & Miao, P. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.146170 · Cited by 10
Kim, C., Kim, D., Nam, D., Chung, W., Ahn, K. S., KIM, S., Choi, S., Shim, B. S., Cho, S. K., & Ahn, K. S. (2014) · Phytotherapy Research · doi:10.1002/ptr.5140 · Cited by 10
“CXCR4 is one of the best-characterized chemokine receptor, which has been shown to induce leukocyte trafficking (Hernandez et al., 2003), mediation of pivotal roles in B cell lymphopoiesis and myelopoiesis (Nagasawa et al.”
BackgroundAbsence of activating mutations of CXCR4 in pituitary tumours
Lee, Y., Noh, T. W., Lee, M. K., Jameson, J. L., & Lee, E. J. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03629.x · Cited by 10
Tsuchida, S., Kagi, A., & Takahashi, T. (2007) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2007.01.008 · Cited by 10
Benign chronic neutropenia with abnormalities involving 16q22, affecting mother and daughter
Glasser, L., Meloni‐Ehrig, A., Joseph, P., & Mendiola, J. A. (2006) · American Journal of Hematology · doi:10.1002/ajh.20550 · Cited by 10
Corey, S. J., & Oyarbide, U. (2017) · Hematology · doi:10.1182/asheducation-2017.1.172 · Cited by 10
“It is an autosomal-dominant disease caused by mutations in CXCR4.(46) CXCR4 encodes C-X-C chemokine receptor type 4, a membrane receptor expressed in cells of both the immune and the central nervous systems.”
BackgroundInfluentialDe novo interstitial deletion 2q14.1q22.1: Is there a recognizable phenotype?
Greally, M. T., Robinson, E., Allen, N. M., O’Donovan, D. J., & Crolla, J. A. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36786 · Cited by 10
“3 CXCR4 162643 Chr2:136,871,919–136,875,735 AD #193670 WHIM syndrome:warts, hypogammaglobulinemia, infections and myelokathexis [Hernandez et al., 2003] 2q22.”
Repositioning Drugs for Rare Immune Diseases: Hopes and Challenges for a Precision Medicine
Valencic, E., Šmid, A., Jakopin, Ž., Tommasini, A., & Mlinarič‐Raščan, I. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666170830101215 · Cited by 12
Mavorixafor: a new hope for WHIM syndrome
Geier, C. B. (2024) · Blood · doi:10.1182/blood.2024024942 · Cited by 10
Meng, X., Zhang, H., Dong, L., Min, Q., Yu, M., Li, Y., Liu, L., Wang, W., Ying, W., Sun, J., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023012171 · Cited by 9
“22,23 Indeed, as depicted in Figure 2A, WHIM displayed a markedly low WBC count because of a signi fi cant reduction in monocytes and lymphocytes in addition to low levels of granulocytes.”
BackgroundGénétique et sensibilité aux papillomavirus: le modèle de l’épidermodysplasie verruciforme
Orth, G. (2010) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32253-8 · Cited by 13
Trivett, M. T., Burke, J. D., Deléage, C., Coren, L. V., Hill, B. J., Jain, S., Barsov, E. V., Breed, M. W., Kramer, J. A., Prete, G. Q. D., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00896-19 · Cited by 12
“the dysregulation of CXCR4 signaling (47, 48).”
Preference of Genetic Diagnosis of CXCR4 Mutation Compared with Clinical Diagnosis of WHIM Syndrome
Aghamohammadi, A., Abolhassani, H., Puchałka, J., Kohistani, N., Zoghi, S., Klein, C., & Rezaei, N. (2017) · Journal of Clinical Immunology · doi:10.1007/s10875-017-0387-5 · Cited by 9
Shearman, J. R., Zhang, Q. Y., & Wilton, A. N. (2006) · Animal Genetics · doi:10.1111/j.1365-2052.2005.01413.x · Cited by 9
Disorders of Granulopoiesis and Granulocyte Function
Laurence, A. D. J., Chowdary, P., & Ancliff, P. (2006) · Wiley eBooks · doi:10.1002/9780470987001.ch14 · Cited by 11
Paige, D. G., Gennery, A. R., & Cant, A. J. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch17 · Cited by 10
Genetic Immunodeficiency Diseases
Abrams, M., & Paller, A. S. (2007) · Advances in Dermatology · doi:10.1016/j.yadr.2007.08.001 · Cited by 9
Common Presentations and Diagnostic Approaches
Rezaei, N., de Vries, E., Gambineri, E., & Haddad, É. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405546-9.00001-7 · Cited by 8
Mechanisms of Sustained Neutrophilia in Patient WHIM-09, Cured of WHIM Syndrome by Chromothripsis
Liu, Q., Li, Z., Yang, A. Y., Gao, J., Velez, D. S., Cho, E., McDermott, D. H., & Murphy, P. M. (2017) · Journal of Clinical Immunology · doi:10.1007/s10875-017-0457-8 · Cited by 8
“Almost all known cases ofWHIM syndrome are caused by gain-of-function mutations in the C-terminus of the chemokine receptor CXCR4 [3].”
Basuli, F., Zhang, X., Phelps, T. E., Jagoda, E. M., Choyke, P. L., & Swenson, R. E. (2020) · Molecules · doi:10.3390/molecules25173924 · Cited by 10
Bidkhori, H. R., Bahrami, A. R., Farshchian, M., Heirani‐Tabasi, A., Mirahmadi, M., Hassanzadeh, H., Ahmadiankia, N., Faridhosseini, R., Dastpak, M., Shabgah, A. G., et al. (2021) · Cell Transplantation · doi:10.1177/09636897211054498 · Cited by 8
The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy
Schlecht‐Louf, G., Deback, C., & Bachelerie, F. (2022) · Cancers · doi:10.3390/cancers14030848 · Cited by 9
Yan, S. R., Bortolussi, R. A., Issekutz, T. B., & Issekutz, A. C. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.06.004 · Cited by 10
Update on childhood neutropenia: molecular and clinical advances
Dror, Y., & Sung, L. (2004) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2004.06.013 · Cited by 8
“Recently, mutations in the chemokine receptor gene, CXCR4, were identified as the cause of the WHIM syndrome [38].”
BackgroundSuresh, R., Chiriac, A. E., Goel, K., Villarraga, H. R., López-Jiménez, F. A., Thomas, R. J., Terzic, A., Nelson, T. J., & Pérez-Terzic, C. M. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9502-z · Cited by 8
Álvarez, I., Pérez-Pardal, L., Traoré, A., Fernández, I., & Goyache, F. (2016) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2016.04.029 · Cited by 8
Le syndrome de Whim : une cause exceptionnelle de bronchiectasies diffuses
Vinurel, H., Freymond, N., Pachéco, Y., & Devouassoux, G. (2008) · Revue des Maladies Respiratoires · doi:10.1016/s0761-8425(08)71621-8 · Cited by 8
A novel transmembrane CXCR4 variant that expands the WHIM genotype-phenotype paradigm
Zmajkovicova, K., Pawar, S., Sharapova, S. O., Geier, C. B., Wiest, I., Nguyen, C., Monticelli, H., Maier-Munsa, S., Chen, K. S., Sleasman, J. W., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023011875 · Cited by 7
Immunodeficiency: Quantitative and qualitative phagocytic cell defects
Mickey, D., Camacho, J. V., Khan, A., & Kaufman, D. (2024) · Allergy and Asthma Proceedings · doi:10.2500/aap.2024.45.240049 · Cited by 9
Micewicz, E. D., & Ruchala, P. P. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319100003 · Cited by 7
Targeting cell adhesion and homing as strategy to cure Waldenström's macroglobulinemia
Pals, S. T., Kersten, M. J., & Spaargaren, M. (2016) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2016.08.019 · Cited by 8
“These mutations are identical or similar to those associated with Warts, Hypogammaglobulinemia, Infection and Myelokathexis (WHIM) syndrome, a rare autosomal dominant genetic disorder, and confer gain of function by decreasing CXCR4 internalization, resulting in enhanced ERK1/2 phosphorylation and chemotaxis [15,34].”
BackgroundPeng, Y., Yang, T., Tang, X., Chen, F., & Wang, S. (2019) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-019-00898-x · Cited by 7
Orth, G. (2006) · Springer eBooks · doi:10.1007/2-287-28699-3_1 · Cited by 15
ALLISON, A. C. (2008) · Public Health Genomics · doi:10.1159/000154817 · Cited by 7
Function of Chemokines and Their Receptors in Immunity
Thelen, M., & Uguccioni, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.10008-6 · Cited by 8
Evaluation of the Patient with Suspected Immunodeficiency
Holland, S. M., & Gallin, J. I. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00012-6 · Cited by 7
Trafficking of Osteoclast Precursors
Kikuta, J., Nevius, E., Ishii, M., & Pereira, J. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00003-7 · Cited by 7
How Recent Advances in Biology of Waldenström’s Macroglobulinemia May Affect Therapy Strategy
Baron, M., Simon, L., Poulain, S., & Leblond, V. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0768-4 · Cited by 6
Periodontal disease in patients with WHIM syndrome
Brenchley, L., McDermott, D. H., Gardner, P. J., Silva, L. M., Gao, J., Cho, E., Velez, D. S., Moutsopoulos, N. M., Murphy, P. M., & FRASER, D. D. (2024) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13940 · Cited by 6
Klinischer Algorithmus zur Therapie von kutanen, extragenitalen HPV-induzierten Warzen
Rübben, A. (2011) · Der Hautarzt · doi:10.1007/s00105-010-2027-3 · Cited by 6
Genetic Syndromes with Evidence of Immune Deficiency
Ming, J. E., & Graham, J. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405546-9.00012-1 · Cited by 7
Evaluation of the Patient with Suspected Immunodeficiency
Holland, S. M., & Gallin, J. I. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00012-6 · Cited by 6
Analysis of Chemokine Receptor Trafficking by Site-Specific Biotinylation
Liebick, M., Schläger, C., & Oppermann, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157502 · Cited by 6
Common presentations and diagnostic approaches
Rezaei, N., de Vries, E., Gambineri, E., Meyts, I., & Haddad, É. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816768-7.00001-6 · Cited by 7
Déficits immunitaires primitifs de révélation tardive
Bussone, G., & Mouthon, L. (2009) · La Presse Médicale · doi:10.1016/j.lpm.2009.04.006 · Cited by 6
Neutropénies constitutionnelles et acquises
Donadieu, J., & Fenneteau, O. (2005) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/j.emch.2005.07.002 · Cited by 6
CXCR4, un récepteur de chimiokine aux multiples talents
Desjardins, S. F., Berchiche, Y. A., Haddad, É., & Heveker, N. (2007) · médecine/sciences · doi:10.1051/medsci/20072311980 · Cited by 6
“Cette neutropénie est caractérisée par une rétention anormale de neutrophiles matures dans la moelle osseuse [8].”
BackgroundThe duality of chemokines in heart failure
Jarrah, A. A., & Tarzami, S. T. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.1024658 · Cited by 7
“WHIM syndrome is caused by heterozygous truncating mutations in the cytoplasmic tail domain of the gene encoding CXCR4 [126].”
BackgroundMechanisms of Disordered Granulopoiesis in Congenital Neutropenia
Grenda, D. S., & Link, D. C. (2006) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)74005-4 · Cited by 6
Demenego, G., Mancinelli, S., Borreca, A., Proce, R. O., Aragona, V., Miotto, M., Cremonesi, M., Zucchelli, L., Corradini, I., Kim, E., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.05.016 · Cited by 6
Implications of CXCR4/CXCL12 Interaction for Cancer Stem Cell Maintenance and Cancer Progression
Peitzsch, C., Cojoc, M., Kurth, I., & Dubrovska, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-21030-8_4 · Cited by 6
CXCR4, une cible thérapeutique dans certains déficits immunitaires rares?
Bignon, A., Biajoux, V., Bouchet‐Delbos, L., Émilie, D., Lortholary, O., & Balabanian, K. (2011) · médecine/sciences · doi:10.1051/medsci/2011274015 · Cited by 5
“Des formes familiales sans anomalie de CXCR4 ont également été identifiées, WHIMsauvage(s), soulignant une hétérogénéité génétique du SW [6, 20].”
BackgroundBurnworth, B., Wang, Z., Singleton, T. P., Bennington, A., Fritschle, W. K., Bennington, R. K., Brodersen, L. E., Wells, D. A., Loken, M. R., & Zehentner, B. K. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.10.008 · Cited by 5
Targeted pharmacologic immunomodulation for inborn errors of immunity
Sacco, K. A., Stack, M., & Notarangelo, L. D. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14509 · Cited by 5
“Mutations in the CXCR4 gene are associated with an immunodeficiency due to dysregulated leucocyte migration.(27) This disorder is termed WHIM syndrome, which stands for warts,”
BackgroundNeutrophils defending the defenders
Singh, R., Sharma, P., & Wadhwan, V. (2021) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_495_20 · Cited by 5
“Hernandez et al.[4] mentioned that granulocyte colony‐stimulating factor (G‐CSF) receptors are maintained at their surface.”
BackgroundCase Report: A Novel CXCR4 Mutation in a Chinese Child With Kawasaki Disease Causing WHIM Syndrome
Ma, X., Wang, Y., Wu, P. S., Kang, M., Hong, Y., Xue, Y., Chen, C., Li, H., & Fang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.857527 · Cited by 5
“In 2003, George Diaz first confirmed that this disease is caused by heterozygous mutations of CXCR4 gene (4).”
Waldenström Macroglobulinemia and Non-IgM-Type Lymphoplasmacytic Lymphoma Are Genetically Similar
Awata, M., Yokohama, A., Kanai, Y., Gotoh, N., Kasamatsu, T., Handa, H., Saitoh, T., Murakami, H., Hirato, J., Ikota, H., et al. (2023) · Acta Haematologica · doi:10.1159/000530100 · Cited by 5
Chemokines and other cytokines in human immunodeficiency virus type 1 (HIV-1) infection
Llano, A., & Esté, J. A. (2005) · Cited by 6
Working Toward a Genomic Prognostic Classification of Waldenström Macroglobulinemia
Magierowicz, M., Tomowiak, C., Leleu, X. P., & Poulain, S. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.05.007 · Cited by 6
Gao, J., Owusu-Ansah, A., Paun, A., Beacht, K., Yim, E., Siwicki, M. R., Yang, A. Y., Liu, Q., McDermott, D. H., & Murphy, P. M. (2019) · JCI Insight · doi:10.1172/jci.insight.132140 · Cited by 6
“Introduction Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome is a rare, combined primary immunodeficiency disease caused in almost all cases by autosomal dominant, gain-of-function mutations in the gene encoding chemokine receptor CXCR4 (1, 2).”
BackgroundBoulais, P. E., Escher, E., & Leduc, R. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.11.022 · Cited by 5
Unexpected developments in immune organs in WHIM syndrome
Murphy, P. M., & McDermott, D. H. (2012) · Blood · doi:10.1182/blood-2012-04-420752 · Cited by 5
A report of WHIM syndrome (myelokathexis)
Naoum, F. A. (2011) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.5581/1516-8484.20110105 · Cited by 5
“(6) In 2003, Hernandez et al.(7) reported that this syndrome is caused by a gain in function of a mutation in the CXC chemokine receptor 4 (CXCR4) causing partial truncation of this receptor.”
BackgroundMing, J. E., & Stiehm, E. R. (2016) · Springer eBooks · doi:10.1007/978-3-662-52909-6_10 · Cited by 5
Hutchison, R. E., & Schexneider, K. I. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00033-6 · Cited by 7
Diagnostic des déficits immunitaires primitifs à l’âge adulte
Mouthon, L., BEREZNE, A., Guillevin, L., & Lassoued, K. (2006) · La Presse Médicale · doi:10.1016/s0755-4982(06)74710-8 · Cited by 5
Human B Cell Development and Tolerance
Kienzler, A., & Eibel, H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.01016-x · Cited by 8
Nguyen, C. H., Zmajkovicova, K., Sekirnik, A., Taplin, S., Defontis, M., Bledsoe, J. R., Taveras, A. G., Karlsson, L., & Johnson, R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1658987 · Cited by 4
Wang, W., Pope, A., Ward-Shaw, E. T., Buehler, D. G., Bachelerie, F., & Lambert, P. F. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012472 · Cited by 4
Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome
McDermott, D. H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405546-9.00035-2 · Cited by 4
CXCR4 antagonism ameliorates leukocyte abnormalities in a preclinical model of WHIM syndrome
Roland, L., Nguyen, C. H., Zmajkovicova, K., Khamyath, M., Kalogeraki, M., Schell, B., Gourhand, V., Rondeau, V., Nader, Z. A., Monticelli, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1468823 · Cited by 4
The Structural Biology of Chemokines
Lolis, E., & Murphy, J. W. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-020-1_2 · Cited by 5
“Some forms of the genetic disease warts-hypogammaglobulinemainfections-myelkathexis (WHIM) syndrome are due to mutants at the cytosolic C-terminal end of CXCR4 ( 8 ).”
BackgroundCao, X., Meng, Q., Cai, H., Mao, Y.-Y., Duan, M. H., Zhu, T. N., Zhang, W., Han, B. J., Zhuang, J. L., Cai, H., et al. (2017) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2017.06.006 · Cited by 4
Jeong, D., Kim, S., Min, B. J., Kim, J. H., Ju, Y. S., Ahn, Y., Yun, J., Lee, Y. E., Kwon, S. R., Park, J. H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-11492-2 · Cited by 4
Elastase-dependent congenital neutropenia
Mazur, A., Skrzeczyńska-Moncznik, J., Majewski, P., & Cichy, J. (2023) · Rare Disease and Orphan Drugs Journal · doi:10.20517/rdodj.2022.12 · Cited by 4
The complex nature of CXCR4 mutations in WHIM syndrome
Rodríguez-Frade, J. M., González‐Granado, L. I., Santiago, C. A., & Mellado, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1406532 · Cited by 4
Metadata
- Authors
- Hernandez, P. A., Gorlin, R. J., Lukens, J. N., Taniuchi, S., Bohinjec, J., Francois, F., Klotman, M. E., & Diaz, G. A.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- University of Minnesota (US)
- Vanderbilt University (US)
- Kansai Medical University (JP)
- Ljubljana University Medical Centre (SI)
- Venue
- Nature Genetics
- Published
- 2003-04-14
- Volume
- 34
- Issue
- 1
- Pages
- 70-74
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2167070743
- Cited by
- 722
- References
- 30
- Citations by year
- 2026: 11 · 2025: 20 · 2024: 40 · 2023: 26 · 2022: 21 · 2021: 25 · 2020: 33 · 2019: 38 · 2018: 39 · 2017: 37 · 2016: 34 · 2015: 37 · 2014: 48 · 2013: 32 · 2012: 35
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- WHIM syndrome, CXCR4, myelokathexis, combined immunodeficiency, neutropenia, hypogammaglobulinemia, HPV infection, calcium flux, autosomal recessive inheritance, genetic heterogeneity, cell-mediated immunity
- MeSH terms
- Agammaglobulinemia, B-Lymphocytes, Base Sequence, Chromosomes, Human, Pair 2, DNA, DNA Mutational Analysis, Female, Humans, Immunologic Deficiency Syndromes, Genetic Linkage, Male, Models, Molecular, Molecular Sequence Data, Mutation, Neutropenia, Pedigree, Warts, Receptors, CXCR4, Calcium Signaling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.